The work analyses the results of treating 20 hypertensive patients with (stage I-II) with betapressin. The drug is shown to be active in causing a significant decrease of systolic and mean arterial pressure. Its hypotensive effect is associated with essential decrease of peripheral vascular resistance.
View Article and Find Full Text PDF